PT1384478E - Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos - Google Patents

Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos Download PDF

Info

Publication number
PT1384478E
PT1384478E PT03020587T PT03020587T PT1384478E PT 1384478 E PT1384478 E PT 1384478E PT 03020587 T PT03020587 T PT 03020587T PT 03020587 T PT03020587 T PT 03020587T PT 1384478 E PT1384478 E PT 1384478E
Authority
PT
Portugal
Prior art keywords
eye
treatment
compositions containing
antibiotic compositions
containing moxifloxacin
Prior art date
Application number
PT03020587T
Other languages
English (en)
Portuguese (pt)
Inventor
John M Yanni
Gerald Cagle
Robert L Abshire
David W Stromann
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1384478(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1384478E publication Critical patent/PT1384478E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT03020587T 1998-09-30 1999-09-29 Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos PT1384478E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10250698P 1998-09-30 1998-09-30
US10250498P 1998-09-30 1998-09-30

Publications (1)

Publication Number Publication Date
PT1384478E true PT1384478E (pt) 2011-05-12

Family

ID=26799441

Family Applications (5)

Application Number Title Priority Date Filing Date
PT141763664T PT2796138T (pt) 1998-09-30 1999-09-29 Composições antibióticas para tratamento da conjuntivite
PT03020587T PT1384478E (pt) 1998-09-30 1999-09-29 Composi??es de antibi?tico que cont?m moxifloxacina para o tratamento dos olhos
PT101786572T PT2301541E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento dos olhos
PT99956504T PT1117401E (pt) 1998-09-30 1999-09-29 Composicoes antibioticas para o tratamento do olho
PT101764124T PT2269602E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento do ouvido

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT141763664T PT2796138T (pt) 1998-09-30 1999-09-29 Composições antibióticas para tratamento da conjuntivite

Family Applications After (3)

Application Number Title Priority Date Filing Date
PT101786572T PT2301541E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento dos olhos
PT99956504T PT1117401E (pt) 1998-09-30 1999-09-29 Composicoes antibioticas para o tratamento do olho
PT101764124T PT2269602E (pt) 1998-09-30 1999-09-29 Composições de antibiótico para o tratamento do ouvido

Country Status (18)

Country Link
EP (5) EP2301541B1 (hu)
JP (5) JP2002525317A (hu)
KR (1) KR101463243B1 (hu)
CN (2) CN100374114C (hu)
AR (2) AR020661A1 (hu)
AT (2) ATE254458T1 (hu)
AU (1) AU762827B2 (hu)
BR (1) BRPI9914151B1 (hu)
CA (3) CA2342211C (hu)
CY (3) CY1111404T1 (hu)
DE (2) DE69943287D1 (hu)
DK (5) DK2796138T3 (hu)
ES (4) ES2526521T3 (hu)
HK (4) HK1150769A1 (hu)
PT (5) PT2796138T (hu)
TR (2) TR200100883T2 (hu)
TW (1) TWI222361B (hu)
WO (1) WO2000018386A2 (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
AU776609B2 (en) 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
US6462033B2 (en) 2000-07-26 2002-10-08 Alcon Universal Ltd. Process for manufacturing compositions containing ciprofloxacin and hydrocortisone
WO2002040028A1 (fr) * 2000-11-16 2002-05-23 Wakamoto Pharmaceutical Co., Ltd. Gouttes pour les yeux en gel antibacterien
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2002226926A1 (en) * 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
ATE313328T1 (de) 2001-09-21 2006-01-15 Alcon Inc Verfahren zur behandlung von mittelohrinfektionen
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
JP2008512383A (ja) * 2004-09-03 2008-04-24 ピードモント ファーマシューティカルズ エルエルシー 中耳炎の経膜治療方法および予防方法
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
EP1824499A2 (en) * 2004-12-10 2007-08-29 Alcon Inc. Compositions for treatment of ear infections
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI495469B (zh) * 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
BRPI1016257B8 (pt) * 2009-07-02 2021-05-25 Alcon Res Ltd composições compreendendo finafloxacina para tratamento de infecções óticas
JP2013516485A (ja) * 2010-01-07 2013-05-13 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 耳にモキシフロキサシンを適用するための方法および組成物
US9138481B2 (en) 2011-12-06 2015-09-22 Alcon Research, Ltd. Cellulosic gel composition with improved viscosity stability
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
JP6474913B2 (ja) * 2015-10-29 2019-02-27 テイカ製薬株式会社 外用剤
JP2021524861A (ja) * 2018-04-03 2021-09-16 ハイデラバード アイ リサーチ ファウンデーション フルオロキノロン系抗生物質の眼内投与のための粘膜付着性薬物送達システム
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
EP4164625A1 (en) * 2020-06-10 2023-04-19 Ocular Science, Inc. Compositions and uses in method for post-operative ocular care
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
CA1325382C (en) * 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
TW209865B (hu) * 1992-01-10 1993-07-21 Bayer Ag
CA2132826C (en) 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
MX9701731A (es) * 1995-06-06 1997-10-31 Bayer Ag Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
BR9812553B1 (pt) * 1997-09-25 2010-06-01 formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
EP1115373B1 (en) 1998-09-23 2004-12-22 Unilever N.V. Oral composition with an improved teeth whitening effect
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법

Also Published As

Publication number Publication date
DK1384478T3 (da) 2011-05-23
ES2519190T3 (es) 2014-11-06
CN1184968C (zh) 2005-01-19
BRPI9914151B8 (hu) 2021-05-25
CA2774207A1 (en) 2000-04-06
EP2796138B1 (en) 2016-08-17
ES2526521T3 (es) 2015-01-13
AU1310100A (en) 2000-04-17
ES2602956T3 (es) 2017-02-23
DE69912972T2 (de) 2004-04-22
AR020661A1 (es) 2002-05-22
CA2342211A1 (en) 2000-04-06
TR200704370T2 (tr) 2007-11-21
CY1115759T1 (el) 2017-01-25
EP1117401A2 (en) 2001-07-25
EP2269602B1 (en) 2014-11-19
JP2012067141A (ja) 2012-04-05
CN100374114C (zh) 2008-03-12
TR200100883T2 (tr) 2001-10-22
DE69943287D1 (de) 2011-04-28
CY1115916T1 (el) 2017-01-25
JP2014144982A (ja) 2014-08-14
JP2013018799A (ja) 2013-01-31
CA2342211C (en) 2009-05-26
AU762827B2 (en) 2003-07-03
HK1038691A1 (en) 2002-03-28
DK2301541T3 (da) 2014-09-01
EP2796138A1 (en) 2014-10-29
ES2207307T3 (es) 2004-05-16
CN1650863A (zh) 2005-08-10
WO2000018386A2 (en) 2000-04-06
AR081393A2 (es) 2012-08-29
JP5563041B2 (ja) 2014-07-30
CA2659064A1 (en) 2000-04-06
BR9914151A (pt) 2001-06-26
ATE254458T1 (de) 2003-12-15
DK1117401T3 (da) 2004-02-23
EP1384478B1 (en) 2011-03-16
JP2009007375A (ja) 2009-01-15
KR101463243B1 (ko) 2014-12-17
DE69912972D1 (de) 2003-12-24
HK1059572A1 (en) 2004-07-09
WO2000018386A3 (en) 2000-06-08
EP2301541A1 (en) 2011-03-30
PT2796138T (pt) 2016-09-22
DK2796138T3 (en) 2016-12-05
KR20010075138A (ko) 2001-08-09
EP1117401B1 (en) 2003-11-19
HK1150756A1 (en) 2012-01-13
JP2002525317A (ja) 2002-08-13
BRPI9914151B1 (pt) 2017-10-03
CN1320035A (zh) 2001-10-31
HK1150769A1 (en) 2012-01-13
DK2269602T3 (en) 2014-12-15
ATE501732T1 (de) 2011-04-15
PT2301541E (pt) 2014-10-29
PT1117401E (pt) 2004-03-31
EP2301541B1 (en) 2014-08-20
EP1384478A1 (en) 2004-01-28
PT2269602E (pt) 2014-12-29
TWI222361B (en) 2004-10-21
EP2269602A1 (en) 2011-01-05
CY1111404T1 (el) 2015-08-05
HK1038691B (zh) 2004-04-23

Similar Documents

Publication Publication Date Title
HK1059572A1 (en) Antibiotic compositions containing moxifloxacin for treatment of the eye
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HK1038693A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
HK1038889A1 (en) Stabilization of rapamycins or derivatives of rapamycins
HUP0203619A3 (en) Moxifloxacin compositions containing common salt and process for its preparation
HK1038692A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
HK1038694A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
IL146162A0 (en) Macrolide compounds for the treatment of dry eye
HUP0102836A3 (en) Use of oxazolidinones for preparation of pharmaceutical compositions suitable for treating eye infections
AU2021601A (en) Composition for the treatment of dandruff
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
AU4144000A (en) Compositions for treating brain infarction
EP1096927A4 (en) STRESS TREATMENT COMPOSITION
AU2683500A (en) Compositions for the treatment of pain
EP1084105A4 (en) CARBAPENEM ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF TREATMENT
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
EP1032384A4 (en) ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING CARBAPENEMAS
EP1027352A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPOSITIONS AND TREATMENT METHODS
EP1027353A4 (en) ANTIBACERIAL CARBAPENEM COMPOUNDS, COMPOSITIONS THAT CONTAIN THESE AND TREATMENT METHODS
EP1089730A4 (en) CARBAPENEM-BASED ANTIBACTERIAL COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC METHODS
EP1089729A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPILATIONS THAT CONTAIN THEM AND TREATMENT METHODS
IL119219A0 (en) Pharmaceutical compositions for treatment of the eyes
IL110895A0 (en) Pharmaceutical compositions for treatment of the eyes
IL124878A0 (en) Composition for the treatment of seborrhea
GB9806431D0 (en) Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment